Cas no for 610309-89-2,Carvedilol phosphate hemihydrate ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 610309-89-2

610309-89-2

[CAS Name] Carvedilol phosphate hemihydrate

[Formula] C48H60N4O17P2

Search Products Post Sourcing Request

Basica Info

[CAS Name]Carvedilol phosphate hemihydrate
[Alias]1-(9H-Carbozol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol phosphate hydrate (2:2:1); Carvedilol Phosphate; 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol phosphate hydrate (2:2:1)
[Number]610309-89-2
[EINECS]
[Formula]C48H60N4O17P2
[Molecular weight]1026.9541

[Boiling point]655.2°C at 760 mmHg
[Density]4.63E-18mmHg at 25°C
[Flash point]350.1°C

610309-89-2 Suppliers

Company

Main Products

Zhejiang Huahai Pharmaceutical Co., Ltd.

please call me ， to know more

Send Inquiry

Shenyang Chengtai Fine Chemicals Factory

Send Inquiry

ZF Polpharma S.A.

Carvedilol phosphate hemihydrate

Long experience in in-house commercial manufacturing
Tailor-made PSD
Secure and high-quality intermediate sources

Status	Commercial
Therapeutic cat.	Cardiology
Polymorphic form	Form I
CAS No.	610309-89-2
EU DMF readiness
US DMF readiness

Drug description

Carvedilol is a beta-blocker. Beta-blockers affect the heart and circulation (blood flow through arteries and veins). Carvedilol is used to treat heart failure and hypertension (high blood pressure). It is also used after a heart attack that has caused your heart not to pump as well. Carvedilol may also be used for purposes not listed in this medication guide.

Disclaimer

Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

Send Inquiry